Health and Happiness (H&H) International Holdings Limited - 1112.HK

1112.HK Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
1112.HK	0.8	3.3	-5.9	-15.5	-1.2	-18.3	-35	-77.2	-45.9	-18.8
S&P 500	1.0	1.5	1.1	2.3	8.9	23.6	33.8	80.6	196.5	33856.2

Compare 1112.HK with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	1112.HK
name	Health and Happiness (H&H) International Holdings Limited
price	8.45
changes percentage	0.8353
change	0.07
day low	8.41
day high	8.8
year high	12.4
year low	7.6
market cap	5442398944
price avg 50	9.1678
price avg 200	9.4284
exchange	HKSE
volume	170766
avg volume	455995
open	8.8
previous close	8.38
eps	0.46
pe	18.37
earnings announcement	2025-03-24T10:59:00.000+0000
shares outstanding	644070881
timestamp	2025-01-20 08:08:32

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 43.3%

Overall Quarterly Financial Health: 45.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	13926470000	12775914000	9.01
gross profit	8472856000	7703488000	9.99
gross profit ratio	0.61	0.6	0.90
research and development expenses	206077000	158188000	30.27
operating expenses	6640510000	5931513000	11.95
interest income	30227000	20019000	50.99
interest expense	807605000	530292000	52.29
ebitda	2043460000	1872506000	9.13
ebitdaratio	0.15	0.14	6.71
operating income	1832346000	1445483000	26.76
operating income ratio	0.13	0.11	16.29
net income	581845000	611783000	-4.89
net income ratio	0.04	0.05	-12.75
eps	0.9	0.96	-6.25

Overall Score of Annual Income Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 13,926 million in 2023 from 12,776 million in 2022 representing a change of 9.01%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 8,473 million in 2023 from 7,703 million in 2022 representing a change of 9.99%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 206 million in 2023 from 158 million in 2022 representing a change of 30.27%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 2,043 million in 2023 from 1,873 million in 2022 representing a change of 9.13%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 1,832 million in 2023 from 1,445 million in 2022 representing a change of 26.76%. The increase in operating income indicates better operational performance and increased profitability.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 6,641 million in 2023 from 5,932 million in 2022 representing a change of 11.95%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Net Income: Net income decreased to 582 million in 2023 from 612 million in 2022 representing a change of -4.89%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.9 in 2023 from 0.9 in 2022 representing a change of -6.25%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
revenue	6692132000	6945622000	-3.65
gross profit	4116594000	4210410000	-2.23
gross profit ratio	0.62	0.61	1.48
research and development expenses	104035000	121129000	-14.11
operating expenses	3163713000	3501988000	-9.66
interest income	0	403711000	-100.00
interest expense	0	0	NaN
ebitda	1025741000	806589000	27.17
ebitdaratio	0.15	0.12	31.99
operating income	952881000	708422000	34.51
operating income ratio	0.14	0.1	39.60
net income	305803000	-26169000	1268.57
net income ratio	0.05	-0.0	1312.83
eps	0.48	-0.05	1108.40

Overall Score of Quarterly Income Statement

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 6,692 million in 2024Q2 from 6,946 million in 2023Q4 representing a change of -3.65%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 4,117 million in 2024Q2 from 4,210 million in 2023Q4 representing a change of -2.23%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 104 million in 2024Q2 from 121 million in 2023Q4 representing a change of -14.11%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 1,026 million in 2024Q2 from 807 million in 2023Q4 representing a change of 27.17%. The decrease in EBITDA indicates declined operational efficiency and profitability.

• 📈 Positive Indicators

  Operating Expenses: Operating Expenses decreased to 3,164 million in 2024Q2 from 3,502 million in 2023Q4 representing a change of -9.66%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Operating Income: Operating income increased to 953 million in 2024Q2 from 708 million in 2023Q4 representing a change of 34.51%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 306 million in 2024Q2 from -26 million in 2023Q4 representing a change of 1268.57%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.48 in 2024Q2 from 0.48 in 2023Q4 representing a change of 1108.4%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	20041970000	20963025000	-4.39
total liabilities	13746746000	14821172000	-7.25
total equity	6295224000	6141853000	2.50
cash and cash equivalents	1364283000	2303660000	-40.78
short term investments	84328000	4066000	1973.98
long term investments	337308000	421381000	-19.95
total current assets	5133400000	5859419000	-12.39
total non current assets	14908570000	15103606000	-1.29
total current liabilities	8441189000	5134883000	64.39
total non current liabilities	5305557000	9686289000	-45.23
common stock	5519000	5519000	0.00
retained earnings	7190870000	7076890000	1.61
total debt	9222553000	9669435000	-4.62

Overall Score of Annual Balance Sheet

0.56 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 20,042 million in 2023 from 20,963 million in 2022 representing a change of -4.39%. Suggesting a decrease in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 1,364 million in 2023 from 2,304 million in 2022 representing a change of -40.78%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 5,133 million in 2023 from 5,859 million in 2022 representing a change of -12.39%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 8,441 million in 2023 from 5,135 million in 2022 representing a change of 64.39%. This indicates a higher short-term debt burden.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 13,747 million in 2023 from 14,821 million in 2022 representing a change of -7.25%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 6,295 million in 2023 from 6,142 million in 2022 representing a change of 2.5%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 84 million in 2023 from 4 million in 2022 representing a change of 1973.98%. This indicates an increase in short-term investment holdings.

  Retained Earnings: Retained Earnings increased to 7,191 million in 2023 from 7,077 million in 2022 representing a change of 1.61%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 9,223 million in 2023 from 9,669 million in 2022 representing a change of -4.62%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
total assets	20332383000	20041970000	1.45
total liabilities	13872595000	13746746000	0.92
total equity	6459788000	6295224000	2.61
cash and cash equivalents	2379094000	1364283000	74.38
short term investments	4315000	84328000	-94.88
long term investments	322662000	337308000	-4.34
total current assets	5719932000	5133400000	11.43
total non current assets	14612451000	14908570000	-1.99
total current liabilities	9209230000	8441189000	9.10
total non current liabilities	4663365000	5305557000	-12.10
common stock	5519000	5519000	0.00
retained earnings	7402996000	7190870000	2.95
total debt	9592023000	9222553000	4.01

Overall Score of Quarterly Balance Sheet

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 20,332 million in 2024Q2 from 20,042 million in 2023Q4 representing a change of 1.45%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 6,460 million in 2024Q2 from 6,295 million in 2023Q4 representing a change of 2.61%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 2,379 million in 2024Q2 from 1,364 million in 2023Q4 representing a change of 74.38%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 5,720 million in 2024Q2 from 5,133 million in 2023Q4 representing a change of 11.43%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 7,403 million in 2024Q2 from 7,191 million in 2023Q4 representing a change of 2.95%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 13,873 million in 2024Q2 from 13,747 million in 2023Q4 representing a change of 0.92%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 4 million in 2024Q2 from 84 million in 2023Q4 representing a change of -94.88%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 9,209 million in 2024Q2 from 8,441 million in 2023Q4 representing a change of 9.1%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 9,592 million in 2024Q2 from 9,223 million in 2023Q4 representing a change of 4.01%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-933377000	-102410000	-811.41
operating cash flow	1096819000	1469313000	-25.35
free cash flow	1005844000	1366820000	-26.41
capital expenditure	-90975000	-102493000	11.24
depreciation and amortization	302253000	311283000	-2.90
deferred income tax	0	0	NaN
stock based compensation	-3788000	-44542000	91.50
accounts payables	270672000	33371000	711.10
inventory	-72194000	-706744000	89.78
acquisitions net	0	-20143000	100.00
investments in property plant and equipment	-58067000	-102493000	43.35
net cash used for investing activites	-52071000	-104876000	50.35
debt repayment	-710579000	-607836000	-16.90
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-474529000	-233623000	-103.12
net cash used provided by financing activities	-1994607000	-1489801000	-33.88
cash at end of period	1364283000	2297660000	-40.62
accounts receivables	-270672000	-33371000	-711.10
cash at beginning of period	2297660000	2400070000	-4.27

Overall Score of Annual Cashflow Statement

0.12 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -933 million in 2023 from -102 million in 2022 representing a change of -811.41%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 1,097 million in 2023 from 1,469 million in 2022 representing a change of -25.35%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 1,006 million in 2023 from 1,367 million in 2022 representing a change of -26.41%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -91 million in 2023 from -102 million in 2022 representing a change of 11.24%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Stock-Based Compensation: Stock-Based Compensation increased to -4 million in 2023 from -45 million in 2022 representing a change of 91.5%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 271 million in 2023 from 33 million in 2022 representing a change of 711.1%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid decreased to -475 million in 2023 from -234 million in 2022 representing a change of -103.12%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Accounts Receivables: Accounts Receivables decreased to -271 million in 2023 from -33 million in 2022 representing a change of -711.1%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
operating cash flow	1052540000	1074750000	-2.07
free cash flow	1030729000	1045152000	-1.38
capital expenditure	-21811000	-29598000	26.31
depreciation and amortization	148141000	152373000	-2.78
deferred income tax	0	0	NaN
stock based compensation	4282000	-15967000	126.82
accounts receivables	-6573000	-110255000	94.04
accounts payables	0	0	NaN
inventory	404217000	147159000	174.68
acquisitions net	0	0	NaN
investments in property plant and equipment	-21811000	-29598000	26.31
net cash used for investing activites	8389000	-32762000	125.61
debt repayment	295634000	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	-474529000	100.00
net cash used provided by financing activities	-86704000	-1788950000	95.15
net change in cash	2379094000	-773441000	407.60
cash at end of period	2379094000	1364283000	74.38
cash at beginning of period	0	2137724000	-100.00

Overall Score of Quarterly Cashflow Statement

0.29 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 2,379 million in 2024Q2 from -773 million in 2023Q4 representing a change of 407.6%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Dividends Paid: Dividends Paid increased to 0 million in 2024Q2 from -475 million in 2023Q4 representing a change of 100.0%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 1,053 million in 2024Q2 from 1,075 million in 2023Q4 representing a change of -2.07%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 1,031 million in 2024Q2 from 1,045 million in 2023Q4 representing a change of -1.38%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -22 million in 2024Q2 from -30 million in 2023Q4 representing a change of 26.31%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Stock-Based Compensation: Stock-Based Compensation increased to 4 million in 2024Q2 from -16 million in 2023Q4 representing a change of 126.82%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to -7 in 2024Q2 from -110 million in 2023Q4 representing a change of 94.04%. This suggests that the company is less capable of collecting payments from its customers.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	21.54	19.96	7.92
net income per share	0.9	0.96	-5.84
operating cash flow per share	1.7	2.3	-26.10
free cash flow per share	1.56	2.14	-27.15
cash per share	2.24	3.61	-37.86
book value per share	9.74	9.6	1.47
tangible book value per share	-10.99	-11.22	2.02
shareholders equity per share	9.74	9.6	1.47
interest debt per share	15.51	15.94	-2.65
market cap	7076326477.76	9415369636.03	-24.84
enterprise value	14934596477.76	16781144636.03	-11.00
pe ratio	12.16	15.39	-20.98
price to sales ratio	0.51	0.74	-31.05
pocfratio	6.45	6.41	0.68
pfcf ratio	7.04	6.89	2.13
pb ratio	1.12	1.53	-26.67
ptb ratio	1.12	1.53	-26.67
ev to sales	1.07	1.31	-18.36
enterprise value over ebitda	7.31	8.96	-18.45
ev to operating cash flow	13.62	11.42	19.22
ev to free cash flow	14.85	12.28	20.94
earnings yield	0.08	0.06	26.54
free cash flow yield	0.14	0.15	-2.09
debt to equity	1.47	1.57	-6.95
debt to assets	0.46	0.46	-0.24
net debt to ebitda	3.85	3.93	-2.24
current ratio	0.61	1.14	-46.71
interest coverage	2.27	2.73	-16.76
income quality	1.17	1.43	-17.57
dividend yield	0.07	0.02	170.26
payout ratio	0.82	0.38	113.57
sales general and administrative to revenue	0.06	0.06	5.24
research and ddevelopement to revenue	0.01	0.01	19.51
intangibles to total assets	0.67	0.64	5.22
capex to operating cash flow	0.08	0.07	18.91
capex to revenue	0.01	0.01	-18.57
capex to depreciation	0.3	0.33	-8.59
stock based compensation to revenue	-0.0	-0.0	92.20
graham number	14.04	14.37	-2.25
roic	0.07	0.05	37.01
return on tangible assets	0.09	0.08	9.44
graham net net	-15.96	-16.63	4.04
working capital	-3307789000	724536000	-556.54
tangible asset value	-7107707000	-7181547000	1.03
net current asset value	-8613346000	-8961753000	3.89
invested capital	10611807000	14579038000	-27.21
average receivables	914652499.5	754154000	21.28
average payables	1190823499.5	1111214000	7.16
average inventory	2481251000	2337710500	6.14
days sales outstanding	27.79	21.97	26.48
days payables outstanding	69.65	96.49	-27.82
days of inventory on hand	158.94	186.2	-14.64
receivables turnover	13.14	16.61	-20.93
payables turnover	5.24	3.78	38.54
inventory turnover	2.3	1.96	17.15
roe	0.09	0.1	-7.21
capex per share	0.14	0.16	-12.13

• ROE:

  Debt-to-Equity Ratio:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 12.16 on 2023-12-31 from 15.39 on 2022-12-31, representing a change of -20.98%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio decreased to 0.61 on 2023-12-31 from 1.14 on 2022-12-31, representing a change of -46.71%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

• Quarterly Financial Ratios

	2024-06-30 Q2	2023-12-31 Q4	Q/Q change %
1112.HK
calendar year	2024	2023	NaN
revenue per share	10.44	12.63	-17.37
net income per share	0.48	-0.05	1102.17
operating cash flow per share	1.64	1.96	-16.01
free cash flow per share	1.61	1.9	-15.42
cash per share	3.72	2.64	41.10
book value per share	10.08	11.45	-12.00
tangible book value per share	-10.54	-12.93	18.46
shareholders equity per share	10.08	11.45	-12.00
interest debt per share	14.96	16.78	-10.80
market cap	5282856099.61	6017093292.07	-12.20
enterprise value	12495785099.61	13875363292.07	-9.94
pe ratio	4.32	-57.48	107.51
price to sales ratio	0.79	0.87	-8.88
pocfratio	5.02	5.6	-10.35
pfcf ratio	5.13	5.76	-10.97
pb ratio	0.82	0.96	-14.44
ptb ratio	0.82	0.96	-14.44
ev to sales	1.87	2.0	-6.53
enterprise value over ebitda	12.18	17.2	-29.18
ev to operating cash flow	11.87	12.91	-8.04
ev to free cash flow	12.12	13.28	-8.68
earnings yield	0.06	-0.0	1430.98
free cash flow yield	0.2	0.17	12.33
debt to equity	1.48	1.47	1.36
debt to assets	0.47	0.46	2.52
net debt to ebitda	7.03	9.74	-27.82
current ratio	0.62	0.61	2.13
interest coverage	0	0	NaN
income quality	3.44	-41.07	108.38
dividend yield	0	0.08	-100.00
payout ratio	0	-18.13	100.00
sales general and administrative to revenue	0.06	0.06	-0.25
research and ddevelopement to revenue	0.02	0.02	-10.86
intangibles to total assets	0.65	0.67	-2.79
capex to operating cash flow	0.02	0.03	-24.75
capex to revenue	0.0	0.0	-23.52
capex to depreciation	0.15	0.19	-24.20
stock based compensation to revenue	0.0	-0.0	127.83
graham number	10.4	3.5	196.97
roic	0.03	-0.04	188.64
return on tangible assets	0.04	-0.0	1190.47
graham net net	-15.22	-18.76	18.87
working capital	-3489298000	-3307789000	-5.49
tangible asset value	-6758099000	-7107707000	4.92
net current asset value	-8152663000	-8613346000	5.35
invested capital	10214894000	10611807000	-3.74
average receivables	None	None	NaN
average payables	None	None	NaN
average inventory	None	None	NaN
days sales outstanding	14.18	13.74	3.19
days payables outstanding	34.82	34.24	1.69
days of inventory on hand	65.66	78.14	-15.97
receivables turnover	6.35	6.55	-3.09
payables turnover	2.58	2.63	-1.66
inventory turnover	1.37	1.15	19.01
roe	0.05	-0.0	1238.80
capex per share	0.03	0.05	-36.80

• Negative

  ROE: Return on Equity (ROE) increased to 0.05 on 2024-06-30 Q2 from -0.00 on 2023-12-31 Q4, representing a change of 1238.80%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio increased to 0.62 on 2024-06-30 Q2 from 0.61 on 2023-12-31 Q4, representing a change of 2.13%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. However, it's below 1, indicating potential liquidity issues.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 4.32 on 2024-06-30 Q2 from -57.48 on 2023-12-31 Q4, representing a change of 107.51%. Indicating an increase in the relative valuation of the company's stock.

• Debt-to-Equity Ratio:

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None